Alternate Delivery of Potent Antiangiogenic Agent-AdPEDF

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$139,924.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43EY015594-01
Agency Tracking Number:
EY015594
Solicitation Year:
2004
Solicitation Topic Code:
n/a
Solicitation Number:
PHS2004-2
Small Business Information
GENVEC, INC.
GENVEC, INC., 65 W WATKINS MILL RD, GAITHERSBURG, MD, 20878
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
LISA Wei
(240) 632-5539
LWEI@GENVEC.COM
Business Contact:
C KING
(240) 632-5537
RKING@GENVEC.COM
Research Institution:
n/a
Abstract
DESCRIPTION (provided by applicant) Exudative age-related macular degeneration (AMD) and proliferative diabetic retinopathy (DR), due to aberrant choroidal and retinal neovascularization respectively, are two of the leading major causes of blindness in th

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government